Skip to Content

Chlorothiazide Sodium Injection

Last Updated: May 4, 2020
Status: Current

Products Affected - Description
    • Sodium Diuril injection, Akorn, 500 mg, vial, 1 count, NDC 76478-0711-40
    • Chlorothiazide injection, Akorn, 500 mg, vial, 1 count, NDC 17478-0419-40
    • Chlorothiazide injection, Sagent, 500 mg, vial, 1 count, NDC 25021-0305-20
Reason for the Shortage
    • Akorn has chlorothiazide on allocation due to increased demand.
    • American Regent did not provide a reason for the shortage.
    • Fresenius Kabi did not provide a reason for the shortage.
    • Sagent has chlorothiazide injection on shortage due to manufacturing delays.
    • Sun Pharma is not marketing chlorothiazide injection.
Available Products
    • Chlorothiazide injection, American Regent, 500 mg, vial, 1 count, NDC 00517-1820-01
    • Chlorothiazide injection, Fresenius Kabi, 500 mg, vial, 1 count, NDC 63323-0658-20
    • Chlorothiazide injection, Mylan Institutional, 500 mg, vial, 1 count, NDC 67457-0263-30

Estimated Resupply Dates

    • Akorn has chlorothiazide 500 mg vials and Diuril 500 mg vials on allocation.
    • Sagent has chlorothiazide 500 mg vials on back order and the company estimates a release date of May 2020.

Updated

Updated May 4, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. Created March 6, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide